If you have PCOS, you've probably heard the word "insulin" thrown around a lot. Maybe your doctor mentioned it. Maybe you fell down a TikTok rabbit hole at midnight and came out more confused than when you started.

Here's what most people don't tell you clearly: PCOS and diabetes are not the same thing. But they share a common root — and that root is insulin resistance. Understanding how they're connected isn't about catastrophising your diagnosis. It's about getting the full picture so you can actually do something with it.

Because you're not imagining it. Your body is trying to tell you something. And when you understand the mechanism, the fog lifts.

This is what I wish someone had told me when I was first diagnosed.

PCOS increases the risk of type 2 diabetes primarily through insulin resistance — a metabolic state where cells don't respond normally to insulin, disrupting blood sugar regulation.

Polycystic Ovary Syndrome is a hormonal condition. Type 2 diabetes is a metabolic one. At first glance, they seem like they live in different departments. But they share a core dysfunction: the way your body handles insulin.

Insulin is the hormone that unlocks your cells so glucose can enter and be used for energy. When insulin resistance develops, your cells stop responding properly. Your pancreas compensates by pumping out more insulin. That excess insulin doesn't just affect your blood sugar — it signals the ovaries to produce more androgens (testosterone), which drives many classic PCOS symptoms like acne, hair growth, and irregular cycles.

The relationship goes both ways. Elevated androgens can worsen insulin resistance. Insulin resistance drives androgen excess. It's a loop — and it's important to understand that you're not dealing with two separate problems. You're often dealing with one metabolic story playing out in multiple ways.

Research confirms this clearly. Studies show that up to 40% of women with PCOS may develop prediabetes, and approximately 10% will go on to develop type 2 diabetes over time [Liao et al., 2022]. Those aren't numbers designed to scare you. They're numbers that say: this is worth paying attention to now, not later.

Insulin resistance causes the pancreas to overproduce insulin, which raises androgen levels in PCOS and impairs blood sugar regulation — the shared mechanism linking both conditions.

Think of insulin resistance like a door that's become stiff. Your body keeps producing more keys (insulin), but the door won't open properly. Over time, the pancreas exhausts itself trying to keep up. Blood glucose levels creep upward. And in women with PCOS specifically, that excess insulin stimulates the ovaries to overproduce testosterone.

This is why insulin resistance is the thread running through so much of what PCOS looks like on the surface. The weight gain around the abdomen. The sugar cravings that hit hard in the afternoon. The energy crash after meals. The irregular periods. The acne. These aren't random. They're often connected by the same root cause.

The research on this is actually pretty clear [Livadas et al., 2022; Barber & Franks, 2012]. Women with PCOS show significantly higher rates of insulin resistance even when matched for body weight with women who don't have PCOS. That's an important point: this isn't only about weight. Lean women with PCOS can be insulin resistant too.

Pancreatic beta-cell dysfunction is also more common in women with PCOS. Beta cells are the cells in your pancreas responsible for producing insulin. When they don't function optimally, it compounds the challenge of keeping blood glucose stable — even in women who aren't yet at a diabetic threshold.

Shared symptoms include fatigue, weight gain (especially around the abdomen), intense sugar cravings, brain fog, acanthosis nigricans (dark skin patches), and unstable energy — all driven by poor insulin and glucose regulation.

You might recognise several of these:

• Fatigue that doesn't make sense — you slept, you ate, and you're still exhausted. This often comes from your cells not being able to use glucose efficiently for energy.
• Abdominal weight gain — visceral fat (the fat around your organs) is both a driver and a consequence of insulin resistance.
• Sugar cravings and energy crashes — when blood glucose spikes and drops, your body signals urgency for quick-release carbohydrates.
• Brain fog — impaired glucose metabolism affects cognitive clarity, especially in the luteal phase if your cycle is involved too.
• Acanthosis nigricans — dark, slightly velvety patches of skin around the neck, armpits, or groin. This is a physical marker of insulin resistance that's often dismissed or unrecognised.
• Irregular periods — excess insulin drives androgen production, which suppresses ovulation and disrupts the cycle.
• Increased thirst and frequent urination — classic signs that blood glucose may be running higher than it should.

Not everyone with PCOS will have all of these. But if several feel familiar, they're not separate inconveniences. They're data points pointing in the same direction.

Key risk factors include obesity, family history of diabetes, elevated androgens, high blood pressure, ethnic background, and impaired results on a glucose tolerance test.

Some of these are in your control. Some aren't. Understanding both matters.

Family history. A genetic predisposition to impaired glucose tolerance or elevated blood sugar doesn't guarantee diabetes, but it does mean the metabolic groundwork may already be laid. If diabetes runs in your family, this is worth knowing and worth monitoring.

Body composition. Excess visceral fat — particularly around the abdomen — significantly worsens insulin resistance. But it's not only about being overweight. Women at a healthy weight with PCOS can still have metabolic dysfunction. Body composition matters more than the number on the scale.

Androgen excess. Higher testosterone levels in PCOS independently worsen insulin sensitivity [Barber & Franks, 2012]. This is one reason why managing androgen levels isn't just about skin and hair — it's a metabolic issue too.

Elevated blood pressure. Hypertension and insulin resistance often travel together. If your blood pressure is consistently higher than it should be, that's relevant metabolic context.

Ethnic background. South Asian, African-Caribbean, and Hispanic women carry a statistically higher risk of developing type 2 diabetes and may show more severe insulin resistance in the context of PCOS.

Impaired glucose tolerance on testing. If you've had a glucose tolerance test and the results were flagged as borderline or impaired, this is one of the strongest predictors of future diabetes risk in women with PCOS.

The oral glucose tolerance test (OGTT) is considered the gold standard for assessing glucose metabolism in PCOS, as it detects impaired glucose tolerance more accurately than fasting glucose or HbA1c alone.

This is a nuance that matters — and one that doesn't always make it into a standard GP appointment.

Fasting plasma glucose (FPG) is commonly used, but it can miss a significant number of women who have impaired glucose tolerance. A woman can have normal fasting glucose but show a problematic response when her body is challenged to process a glucose load. That's the whole point of the OGTT: it shows how your body actually manages glucose under real conditions.

HbA1c — the three-month average blood sugar marker — also has limitations for women with PCOS. Irregular cycles, periods of heavy bleeding, and fluctuating haematocrit levels can affect the reliability of HbA1c readings. So a normal HbA1c doesn't always mean everything is fine metabolically.

If you've been told your bloods are normal based on a single fasting glucose measurement, it's worth asking whether an OGTT has been done. That's not being difficult. That's being informed. And knowing your metabolic status gives you something concrete to act on.

Insulin resistance and metabolic risk associated with PCOS persist throughout a woman's life, including into perimenopause and postmenopause — meaning this isn't a condition to manage only in the reproductive years.

For women of reproductive age, the PCOS-diabetes connection is most active. Insulin resistance is typically highest during this period, and it's compounded by the hormonal environment of the condition itself.

Studies confirm that impaired glucose homeostasis is measurably higher in women with PCOS compared to age- and weight-matched women without PCOS [Liao et al., 2022]. The degree of insulin resistance also escalates with obesity — but again, it's present even without significant weight gain.

This is the period where lifestyle intervention has the most potential. The changes you make now — in your 20s and 30s — compound over time. This isn't about being perfect. It's about building metabolic resilience early.

The hormonal shifts of menopause don't erase the metabolic history of PCOS. Elevated androgen production and impaired glucose tolerance seen in premenopausal women with PCOS often persist after the transition to menopause.

The picture does get more complex. Insulin resistance may improve somewhat in some women during their post-reproductive years, but this isn't consistent and varies significantly depending on PCOS phenotype [Livadas et al., 2022]. Women with hyperandrogenemia tend to show more severe metabolic dysfunction, which continues to carry cardiovascular and metabolic implications.

The honest summary: having PCOS doesn't mean you'll develop diabetes. But the risk doesn't disappear with age. Staying informed and maintaining metabolic awareness throughout life is part of managing this condition well.

The most evidence-backed interventions are balanced blood sugar through diet, consistent resistance training, stress management, and improved sleep — all of which directly improve insulin sensitivity.

Hormonal literacy isn't complicated — it's just rarely taught. So let's break this down practically.

The goal isn't restriction. The goal is blood sugar stability.

• Prioritise protein at every meal. Protein slows glucose absorption and supports muscle mass, which is metabolically active tissue that helps buffer blood sugar.
• Pair carbohydrates with fibre, fat, or protein. Eating carbohydrates alone spikes glucose quickly. Pairing them slows absorption and reduces the insulin demand.
• Reduce ultra-processed foods and refined sugars. These drive glucose spikes and crashes — the exact pattern that worsens insulin resistance over time.
• Consider the evidence behind lower glycaemic eating patterns. Several dietary approaches — including Mediterranean, low-glycaemic, and DASH protocols — have shown measurable benefits for women with PCOS and impaired glucose tolerance.
• Don't eat in a calorie deficit indefinitely. Chronic restriction raises cortisol, worsens insulin resistance, and disrupts the HPA axis. This is why calorie deficit alone rarely solves PCOS.

Movement directly improves insulin sensitivity — but not all movement is equal for women with PCOS.

• Resistance training is particularly effective. Building muscle mass increases your body's ability to take up glucose without requiring as much insulin. Aim for 2–3 sessions per week.
• Walking after meals is underrated. Even a 10–15 minute walk after eating measurably blunts the post-meal glucose spike.
• Be cautious with high-intensity training if you're already burnt out. Excessive HIIT can raise cortisol in women who are already hormonally stressed, which worsens — not improves — insulin resistance in some cases.

These two are often treated as lifestyle nice-to-haves. They're not.

Cortisol directly raises blood glucose. Chronic stress keeps cortisol elevated, keeping blood sugar elevated, keeping insulin elevated. Poor sleep compounds this. A single night of disrupted sleep measurably increases insulin resistance the following day.

Managing stress and prioritising sleep quality aren't soft suggestions. They're metabolic interventions.

Myo-inositol, chromium, and certain B vitamins have the strongest evidence for supporting insulin sensitivity in PCOS — with myo-inositol being the most studied.

This is where the research gets genuinely interesting.

Myo-inositol is a naturally occurring compound in the body — and women with PCOS often have lower levels of it. It plays a direct role in insulin signalling. Multiple studies have shown that myo-inositol supplementation can improve insulin sensitivity, support ovulation, and reduce androgen levels in women with PCOS [Livadas et al., 2022].

Chromium supports the action of insulin at a cellular level, helping glucose enter cells more efficiently. Chromium picolinate specifically has been studied in the context of PCOS and blood sugar management.

Folate (particularly the active form L-5-methyltetrahydrofolate) and B6 support methylation pathways and overall hormonal metabolism — both relevant when managing the broader metabolic picture of PCOS.

This is exactly why we formulated MyoPlus. It combines myo-inositol (in the highly bioavailable Inositol PVP form) with chromium picolinate, active folate, vitamin B6, and magnesium — all working together to support the specific metabolic and hormonal challenges of PCOS. It's not a magic fix. But it gives your body what it's often missing.

If you're managing insulin resistance as part of your PCOS journey, it's worth understanding what the evidence actually supports — and choosing supplements that reflect it.

Metformin is the most commonly prescribed medication for managing insulin resistance in PCOS, sometimes alongside lifestyle changes. An OGTT, thyroid panel, and fasting insulin test are typically the most useful investigations to request.

If lifestyle changes alone aren't moving the needle on your metabolic markers, your doctor may discuss metformin. Originally a type 2 diabetes medication, metformin is commonly prescribed off-label for PCOS because it directly improves insulin sensitivity. It may also support more regular ovulation as a secondary effect.

It's not appropriate for everyone, and it works best alongside — not instead of — lifestyle changes. If you've been prescribed it, it's reasonable to ask your prescribing doctor about expected timelines, monitoring markers, and when to review.

In terms of testing, asking for:

• Fasting insulin and fasting glucose (not just HbA1c)
• An oral glucose tolerance test if insulin resistance is suspected
• Thyroid panel (thyroid dysfunction frequently coexists with PCOS and affects glucose metabolism)
• Full androgen panel (total and free testosterone, DHEAS, SHBG)

...gives you a much more complete metabolic picture than standard bloods alone.

You're not being a difficult patient. You're asking for the information you're entitled to.

PCOS doesn't directly cause diabetes, but it significantly increases the risk. The shared driver is insulin resistance — a metabolic state common in PCOS that, over time and without intervention, can progress to prediabetes and type 2 diabetes. Up to 40% of women with PCOS may develop prediabetes [Liao et al., 2022]. The risk is real, but it's also manageable with early awareness and lifestyle support.

Yes. PCOS and type 2 diabetes are separate diagnoses but frequently coexist. Having PCOS significantly increases lifetime risk of developing type 2 diabetes, particularly in women with obesity, a family history of diabetes, or elevated androgens. If you have both, management strategies overlap considerably — particularly around insulin sensitivity, diet, and physical activity.

Ask for fasting insulin and fasting glucose (separate tests), an oral glucose tolerance test (OGTT) if insulin resistance is suspected, HbA1c as a baseline, and a full thyroid panel. A single fasting glucose result on its own can miss impaired glucose tolerance, which is why the OGTT is considered more reliable for women with PCOS [Livadas et al., 2022].

Yes, frequently. Metformin is a type 2 diabetes medication that works by improving insulin sensitivity. It's prescribed off-label for PCOS to support metabolic function and sometimes to improve cycle regularity. It's typically most effective when combined with lifestyle changes rather than used as a standalone treatment. Speak to your GP or endocrinologist about whether it's appropriate for you.

Absolutely. The research is clear that lifestyle intervention — particularly resistance training, blood sugar-stabilising nutrition, improved sleep, and stress management — measurably improves insulin sensitivity and glucose metabolism [Livadas et al., 2022; Barber & Franks, 2012]. Evidence-based supplements like myo-inositol can also support insulin signalling. Your diagnosis is a starting point, not a verdict. Action taken now matters.

The connection between PCOS and diabetes isn't a reason to panic. It's a reason to get informed.

Your body isn't broken. It's operating in a metabolic environment that needs support — and when you understand what's actually happening, you can make decisions that change the trajectory. Root cause, not symptom suppression.

That means eating in a way that keeps blood sugar stable. Moving in a way that builds insulin sensitivity. Sleeping and managing stress with the same seriousness you apply to diet and exercise. And understanding which supplements and medical options are actually backed by evidence.

If you're ready to take that seriously, Myoplus was formulated specifically to support the metabolic and hormonal needs of women with PCOS — combining myo-inositol, chromium, active folate, and B6 in one daily supplement. It's not a cure. Nothing is. But it's a meaningful part of a wider, smarter approach.

Your diagnosis does not define your future. And you are never powerless.

1. Liao WT, Huang JY, Lee MT, Yang YC, Wu CC. Higher risk of type 2 diabetes in young women with polycystic ovary syndrome: A 10-year retrospective cohort study. World J Diabetes. 2022 Mar 15;13(3):240-250. doi: 10.4239/wjd.v13.i3.240.

2. Livadas S, Anagnostis P, Bosdou JK, Bantouna D, Paparodis R. Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review. World J Diabetes. 2022 Jan 15;13(1):5-26. doi: 10.4239/wjd.v13.i1.5.

3. Barber TM, Franks S. The link between polycystic ovary syndrome and both Type 1 and Type 2 diabetes mellitus: what do we know today? Womens Health (Lond). 2012 Mar;8(2):147-54. doi: 10.2217/whe.11.94.

4. Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology. 2002 Mar;143(3):1076-84. doi: 10.1210/endo.143.3.8691.